Hybrid AI/physics pipeline for miniprotein binder prioritization

This is like a super-smart screening funnel for drug-like mini-proteins. Instead of testing millions of molecules in the lab, it uses a combination of AI predictions and physics-based simulations to quickly sort through candidates and highlight the handful most likely to stick to a disease target.